Pawlick RL - Search Results

1

Ferroptosis-inducing agents compromise in vitro human islet viability and function.

Bruni A, Pepper AR, Pawlick RL, Gala-Lopez B, Gamble AF, Kin T, Seeberger K, Korbutt GS, Bornstein SR, Linkermann A, Shapiro AMJ. Bruni A, et al. Among authors: pawlick rl. Cell Death Dis. 2018 May 22;9(6):595. doi: 10.1038/s41419-018-0506-0. Cell Death Dis. 2018. PMID: 29789532 Free PMC article.

2

Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival.

Nanji SA, Hancock WW, Anderson CC, Adams AB, Luo B, Schur CD, Pawlick RL, Wang L, Coyle AJ, Larsen CP, Shapiro AM. Nanji SA, et al. Among authors: pawlick rl. Am J Transplant. 2004 Apr;4(4):526-36. doi: 10.1111/j.1600-6143.2004.00384.x. Am J Transplant. 2004. PMID: 15023144 Free article.

3

Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.

Luo B, Nanji SA, Schur CD, Pawlick RL, Anderson CC, Shapiro AM. Luo B, et al. Among authors: pawlick rl. Transplantation. 2005 Aug 15;80(3):370-7. doi: 10.1097/01.tp.0000167724.38038.ae. Transplantation. 2005. PMID: 16082333

4

Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.

Nanji SA, Hancock WW, Luo B, Schur CD, Pawlick RL, Zhu LF, Anderson CC, Shapiro AM. Nanji SA, et al. Among authors: pawlick rl. Diabetes. 2006 Jan;55(1):27-33. Diabetes. 2006. PMID: 16380473

5

The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice.

Emamaullee JA, Davis J, Pawlick R, Toso C, Merani S, Cai SX, Tseng B, Shapiro AM. Emamaullee JA, et al. Diabetes. 2008 Jun;57(6):1556-66. doi: 10.2337/db07-1452. Epub 2008 Mar 20. Diabetes. 2008. PMID: 18356409 Free article.

6

Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation.

Toso C, Edgar R, Pawlick R, Emamaullee J, Merani S, Dinyari P, Mueller TF, Shapiro AM, Anderson CC. Toso C, et al. Transpl Int. 2009 Feb;22(2):182-91. doi: 10.1111/j.1432-2277.2008.00746.x. Epub 2008 Aug 15. Transpl Int. 2009. PMID: 18713144 Free article.

7

Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide.

Emamaullee JA, Merani S, Toso C, Kin T, Al-Saif F, Truong W, Pawlick R, Davis J, Edgar R, Lock J, Bonner-Weir S, Knudsen LB, Shapiro AM. Emamaullee JA, et al. Endocrinology. 2009 May;150(5):2145-52. doi: 10.1210/en.2008-1116. Epub 2009 Jan 8. Endocrinology. 2009. PMID: 19131571

8

The use of an approved biodegradable polymer scaffold as a solid support system for improvement of islet engraftment.

Kin T, O'Neil JJ, Pawlick R, Korbutt GS, Shapiro AM, Lakey JR. Kin T, et al. Artif Organs. 2008 Dec;32(12):990-3. doi: 10.1111/j.1525-1594.2008.00688.x. Artif Organs. 2008. PMID: 19133030

9

Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats.

Merani S, Pawlick RL, Edgar RL, Toso C, Emamaullee J, Anderson CC, Shapiro AM. Merani S, et al. Among authors: pawlick rl. Transplantation. 2009 Jan 15;87(1):59-65. doi: 10.1097/TP.0b013e31819198b4. Transplantation. 2009. PMID: 19136892

10

Nonsimultaneous administration of pancreas dissociation enzymes during islet isolation.

Kin T, O'Gorman D, Zhai X, Pawlick R, Imes S, Senior P, Shapiro AM. Kin T, et al. Transplantation. 2009 Jun 15;87(11):1700-5. doi: 10.1097/TP.0b013e3181a60240. Transplantation. 2009. PMID: 19502963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page